RECOGNITION AND MANAGEMENT OF MEDICATION EXCIPIENT REACTIVITY IN PATIENTS WITH MAST CELL ACTIVATION SYNDROME

ABSTRACT Mast cell activation syndrome (MCAS) is a complex disorder hallmarked by chronic multisystem inflammatory, allergic, and growth dystrophic phenomena caused by inappropriate mast cell activation.  MCAS has been estimated to affect as many as 17% of the population with a severity ranging from mild to life-threatening. MCAS patients are more sensitive than the average person to chemicals in the environment, including the non-drug (“inactive”) ingredients (excipients) in medications and supplements. Excipient reactivity may explain unusual side effects to medications health professionals often find puzzling, such as the patient who appears intolerant of prednisone, acetaminophen, levothyroxine, or a vitamin. We present a series of patients with MCAS to illustrate important points regarding excipient reactivity which may be useful in everyday practice.